Martinello Flávia, Roman Camila Fontana, Souza Paula Alves de
Departamento de Análises Clínicas, Centro de Ciências da Saúde, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil.
Arq Gastroenterol. 2017 Apr-Jun;54(2):85-90. doi: 10.1590/S0004-2803.201700000-07. Epub 2017 Feb 23.
Healthy individuals exhibit a significantly higher concentration of faecal bifidobacteria in comparison to celiac patients. Even though there are potential benefits in probiotic usage, they have been little explored as an adjunctive therapy in celiac disease.
This study aimed at the comparison of faecal bifidobacteria concentration and pH among celiac patients and healthy subjects before and after the daily intake of 100 g of yogurt containing probiotic for a thirty-day period.
Feces from 17 healthy subjects and 14 celiac patients were analyzed, in which stool culture was performed for the isolation and quantification of faecal bifidobacteria. Furthermore, Gram's method was employed for the microscopic analysis of the colonies, while the identification of the Bifidobacterium genus was made through determination of the fructose-6-phosphate phosphoketolase enzyme. Faecal pH was measured using a calibrated pHmeter.
Faecal bifidobacteria concentration before probiotic consumption was significantly higher in healthy individuals (2.3x108±6.3x107 CFU/g) when compared to celiac patients (1.0x107±1.7x107 CFU/g). Faecal pH values did not show a significant difference. After the daily consumption of probiotic-containing yogurt both groups showed a significant increase in the concentration of faecal bifidobacteria, but healthy subjects presented significantly higher bifidobacteria concentrations (14.7x108±0.2x108 CFU/g) than the celiac group (0.76x108±0.1x108 CFU/g). The obtained pH values from both groups were not significantly different, being 7.28±0.518 for the celiac patients and 7.07±0.570 for healthy individuals after the probiotic intake.
The probiotic supplementation significantly increased the number of bifidobacteria in the feces of celiac patients, although it was not sufficient to reach the concentration found in healthy individuals prior to its consumption.
与乳糜泻患者相比,健康个体粪便中的双歧杆菌浓度显著更高。尽管益生菌的使用有潜在益处,但在乳糜泻的辅助治疗方面却鲜有探索。
本研究旨在比较乳糜泻患者和健康受试者在每日摄入100克含益生菌酸奶30天前后粪便中双歧杆菌浓度和pH值。
分析了17名健康受试者和14名乳糜泻患者的粪便,进行粪便培养以分离和定量粪便中的双歧杆菌。此外,采用革兰氏法对菌落进行显微镜分析,通过测定6-磷酸果糖磷酸酮醇酶来鉴定双歧杆菌属。使用校准过的pH计测量粪便pH值。
食用益生菌前,健康个体粪便中的双歧杆菌浓度(2.3×10⁸±6.3×10⁷CFU/g)显著高于乳糜泻患者(1.0×10⁷±1.7×10⁷CFU/g)。粪便pH值无显著差异。每日食用含益生菌的酸奶后,两组粪便中双歧杆菌浓度均显著增加,但健康受试者的双歧杆菌浓度(14.7×10⁸±0.2×10⁸CFU/g)显著高于乳糜泻组(0.76×10⁸±0.1×10⁸CFU/g)。两组摄入益生菌后的pH值无显著差异,乳糜泻患者为7.28±0.518,健康个体为7.07±0.570。
补充益生菌显著增加了乳糜泻患者粪便中的双歧杆菌数量,尽管仍不足以达到食用前健康个体中的浓度。